SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pyxis Oncology to Present MICVO Phase 1 Monotherapy Data at EORTC-NCI-AACR Symposium

Pyxis Oncology announced a late-breaking oral presentation of micvotabart pelidotin monotherapy data, alongside two poster presentations, at the EORTC-NCI-AACR symposium.

PYXS

Related stories